<--- Back to Details
First PageDocument Content
Date: 2015-09-01 03:35:21

Press release_Polyphor Ltd POL6014_FPI_Phase I Not to be published before September 1, 2015, 9 am CEST Polyphor extends clinical development portfolio by advancing its inhaled elastase inhibitor POL6014 for lung diseases

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

Download Document from Web Archive

File Size: 31,93 KB